Click for best price
Lung Cancer Diagnostic Tests Market Size, Share 2023
The global Lung Cancer Diagnostic Tests market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Lung Cancer Diagnostic Tests market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Lung Cancer Diagnostic Tests market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Lung Cancer Diagnostic Tests market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This report aims to provide a comprehensive presentation of the global market for Lung Cancer Diagnostic Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Cancer Diagnostic Tests. This report contains market size and forecasts of Lung Cancer Diagnostic Tests in global, including the following market information:
- Global Lung Cancer Diagnostic Tests Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Immunoassays Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Lung Cancer Diagnostic Tests include Advpharma Inc, AIT Austrian Institute of Technology GmbH, Courtagen Life Sciences Inc, DiagnoCure Inc. (Inactive), BioMark Diagnostics Inc., BioMarker Strategies LLC, Emory University, Epigenomics AG and GlycoZym, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Lung Cancer Diagnostic Tests companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lung Cancer Diagnostic Tests Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Lung Cancer Diagnostic Tests Market Segment Percentages, by Type, 2022 (%)
- Immunoassays
- Flow Cytometry
- Rapid Tests
- Molecular Assays
- Tissue Arrays
- Circulating Tumor Cells
- Pharmacodiagnostics
- Biomarkers
- Other Diagnostics Methods
Global Lung Cancer Diagnostic Tests Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Lung Cancer Diagnostic Tests Market Segment Percentages, by Application, 2022 (%)
- Precision Medicine
- Personalized Medicine
- Cancer Monitoring
Global Lung Cancer Diagnostic Tests Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Lung Cancer Diagnostic Tests Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Lung Cancer Diagnostic Tests revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Lung Cancer Diagnostic Tests revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Advpharma Inc
- AIT Austrian Institute of Technology GmbH
- Courtagen Life Sciences Inc
- DiagnoCure Inc. (Inactive)
- BioMark Diagnostics Inc.
- BioMarker Strategies LLC
- Emory University
- Epigenomics AG
- GlycoZym
- HalioDx SAS
- Louisville Bioscience, Inc.
- Mayo Clinic US
Outline of Major Chapters:
Chapter 1: Introduces the definition of Lung Cancer Diagnostic Tests, market overview.
Chapter 2: Global Lung Cancer Diagnostic Tests market size in revenue.
Chapter 3: Detailed analysis of Lung Cancer Diagnostic Tests company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lung Cancer Diagnostic Tests in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Lung Cancer Diagnostic Tests Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
60 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Lung Cancer Diagnostic Tests Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lung Cancer Diagnostic Tests Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lung Cancer Diagnostic Tests Overall Market Size
2.1 Global Lung Cancer Diagnostic Tests Market Size: 2022 VS 2030
2.2 Global Lung Cancer Diagnostic Tests Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Lung Cancer Diagnostic Tests Players in Global Market
3.2 Top Global Lung Cancer Diagnostic Tests Companies Ranked by Revenue
3.3 Global Lung Cancer Diagnostic Tests Revenue by Companies
3.4 Top 3 and Top 5 Lung Cancer Diagnostic Tests Companies in Global Market, by Revenue in 2022
3.5 Global Companies Lung Cancer Diagnostic Tests Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lung Cancer Diagnostic Tests Players in Global Market
3.6.1 List of Global Tier 1 Lung Cancer Diagnostic Tests Companies
3.6.2 List of Global Tier 2 and Tier 3 Lung Cancer Diagnostic Tests Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Lung Cancer Diagnostic Tests Market Size Markets, 2022 & 2030
4.1.2 Immunoassays
4.1.3 Flow Cytometry
4.1.4 Rapid Tests
4.1.5 Molecular Assays
4.1.6 Tissue Arrays
4.1.7 Circulating Tumor Cells
4.1.8 Pharmacodiagnostics
4.1.9 Biomarkers
4.1.10 Other Diagnostics Methods
4.2 By Type - Global Lung Cancer Diagnostic Tests Revenue & Forecasts
4.2.1 By Type - Global Lung Cancer Diagnostic Tests Revenue, 2018-2023
4.2.2 By Type - Global Lung Cancer Diagnostic Tests Revenue, 2024-2030
4.2.3 By Type - Global Lung Cancer Diagnostic Tests Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Lung Cancer Diagnostic Tests Market Size, 2022 & 2030
5.1.2 Precision Medicine
5.1.3 Personalized Medicine
5.1.4 Cancer Monitoring
5.2 By Application - Global Lung Cancer Diagnostic Tests Revenue & Forecasts
5.2.1 By Application - Global Lung Cancer Diagnostic Tests Revenue, 2018-2023
5.2.2 By Application - Global Lung Cancer Diagnostic Tests Revenue, 2024-2030
5.2.3 By Application - Global Lung Cancer Diagnostic Tests Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Lung Cancer Diagnostic Tests Market Size, 2022 & 2030
6.2 By Region - Global Lung Cancer Diagnostic Tests Revenue & Forecasts
6.2.1 By Region - Global Lung Cancer Diagnostic Tests Revenue, 2018-2023
6.2.2 By Region - Global Lung Cancer Diagnostic Tests Revenue, 2024-2030
6.2.3 By Region - Global Lung Cancer Diagnostic Tests Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Lung Cancer Diagnostic Tests Revenue, 2018-2030
6.3.2 US Lung Cancer Diagnostic Tests Market Size, 2018-2030
6.3.3 Canada Lung Cancer Diagnostic Tests Market Size, 2018-2030
6.3.4 Mexico Lung Cancer Diagnostic Tests Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Lung Cancer Diagnostic Tests Revenue, 2018-2030
6.4.2 Germany Lung Cancer Diagnostic Tests Market Size, 2018-2030
6.4.3 France Lung Cancer Diagnostic Tests Market Size, 2018-2030
6.4.4 U.K. Lung Cancer Diagnostic Tests Market Size, 2018-2030
6.4.5 Italy Lung Cancer Diagnostic Tests Market Size, 2018-2030
6.4.6 Russia Lung Cancer Diagnostic Tests Market Size, 2018-2030
6.4.7 Nordic Countries Lung Cancer Diagnostic Tests Market Size, 2018-2030
6.4.8 Benelux Lung Cancer Diagnostic Tests Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Lung Cancer Diagnostic Tests Revenue, 2018-2030
6.5.2 China Lung Cancer Diagnostic Tests Market Size, 2018-2030
6.5.3 Japan Lung Cancer Diagnostic Tests Market Size, 2018-2030
6.5.4 South Korea Lung Cancer Diagnostic Tests Market Size, 2018-2030
6.5.5 Southeast Asia Lung Cancer Diagnostic Tests Market Size, 2018-2030
6.5.6 India Lung Cancer Diagnostic Tests Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Lung Cancer Diagnostic Tests Revenue, 2018-2030
6.6.2 Brazil Lung Cancer Diagnostic Tests Market Size, 2018-2030
6.6.3 Argentina Lung Cancer Diagnostic Tests Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Lung Cancer Diagnostic Tests Revenue, 2018-2030
6.7.2 Turkey Lung Cancer Diagnostic Tests Market Size, 2018-2030
6.7.3 Israel Lung Cancer Diagnostic Tests Market Size, 2018-2030
6.7.4 Saudi Arabia Lung Cancer Diagnostic Tests Market Size, 2018-2030
6.7.5 UAE Lung Cancer Diagnostic Tests Market Size, 2018-2030
7 Lung Cancer Diagnostic Tests Companies Profiles
7.1 Advpharma Inc
7.1.1 Advpharma Inc Company Summary
7.1.2 Advpharma Inc Business Overview
7.1.3 Advpharma Inc Lung Cancer Diagnostic Tests Major Product Offerings
7.1.4 Advpharma Inc Lung Cancer Diagnostic Tests Revenue in Global Market (2018-2023)
7.1.5 Advpharma Inc Key News & Latest Developments
7.2 AIT Austrian Institute of Technology GmbH
7.2.1 AIT Austrian Institute of Technology GmbH Company Summary
7.2.2 AIT Austrian Institute of Technology GmbH Business Overview
7.2.3 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Major Product Offerings
7.2.4 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Revenue in Global Market (2018-2023)
7.2.5 AIT Austrian Institute of Technology GmbH Key News & Latest Developments
7.3 Courtagen Life Sciences Inc
7.3.1 Courtagen Life Sciences Inc Company Summary
7.3.2 Courtagen Life Sciences Inc Business Overview
7.3.3 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Major Product Offerings
7.3.4 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Revenue in Global Market (2018-2023)
7.3.5 Courtagen Life Sciences Inc Key News & Latest Developments
7.4 DiagnoCure Inc. (Inactive)
7.4.1 DiagnoCure Inc. (Inactive) Company Summary
7.4.2 DiagnoCure Inc. (Inactive) Business Overview
7.4.3 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Major Product Offerings
7.4.4 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Revenue in Global Market (2018-2023)
7.4.5 DiagnoCure Inc. (Inactive) Key News & Latest Developments
7.5 BioMark Diagnostics Inc.
7.5.1 BioMark Diagnostics Inc. Company Summary
7.5.2 BioMark Diagnostics Inc. Business Overview
7.5.3 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Major Product Offerings
7.5.4 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Revenue in Global Market (2018-2023)
7.5.5 BioMark Diagnostics Inc. Key News & Latest Developments
7.6 BioMarker Strategies LLC
7.6.1 BioMarker Strategies LLC Company Summary
7.6.2 BioMarker Strategies LLC Business Overview
7.6.3 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Major Product Offerings
7.6.4 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Revenue in Global Market (2018-2023)
7.6.5 BioMarker Strategies LLC Key News & Latest Developments
7.7 Emory University
7.7.1 Emory University Company Summary
7.7.2 Emory University Business Overview
7.7.3 Emory University Lung Cancer Diagnostic Tests Major Product Offerings
7.7.4 Emory University Lung Cancer Diagnostic Tests Revenue in Global Market (2018-2023)
7.7.5 Emory University Key News & Latest Developments
7.8 Epigenomics AG
7.8.1 Epigenomics AG Company Summary
7.8.2 Epigenomics AG Business Overview
7.8.3 Epigenomics AG Lung Cancer Diagnostic Tests Major Product Offerings
7.8.4 Epigenomics AG Lung Cancer Diagnostic Tests Revenue in Global Market (2018-2023)
7.8.5 Epigenomics AG Key News & Latest Developments
7.9 GlycoZym
7.9.1 GlycoZym Company Summary
7.9.2 GlycoZym Business Overview
7.9.3 GlycoZym Lung Cancer Diagnostic Tests Major Product Offerings
7.9.4 GlycoZym Lung Cancer Diagnostic Tests Revenue in Global Market (2018-2023)
7.9.5 GlycoZym Key News & Latest Developments
7.10 HalioDx SAS
7.10.1 HalioDx SAS Company Summary
7.10.2 HalioDx SAS Business Overview
7.10.3 HalioDx SAS Lung Cancer Diagnostic Tests Major Product Offerings
7.10.4 HalioDx SAS Lung Cancer Diagnostic Tests Revenue in Global Market (2018-2023)
7.10.5 HalioDx SAS Key News & Latest Developments
7.11 Louisville Bioscience, Inc.
7.11.1 Louisville Bioscience, Inc. Company Summary
7.11.2 Louisville Bioscience, Inc. Business Overview
7.11.3 Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Major Product Offerings
7.11.4 Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Revenue in Global Market (2018-2023)
7.11.5 Louisville Bioscience, Inc. Key News & Latest Developments
7.12 Mayo Clinic US
7.12.1 Mayo Clinic US Company Summary
7.12.2 Mayo Clinic US Business Overview
7.12.3 Mayo Clinic US Lung Cancer Diagnostic Tests Major Product Offerings
7.12.4 Mayo Clinic US Lung Cancer Diagnostic Tests Revenue in Global Market (2018-2023)
7.12.5 Mayo Clinic US Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Lung Cancer Diagnostic Tests Market Opportunities & Trends in Global Market
Table 2. Lung Cancer Diagnostic Tests Market Drivers in Global Market
Table 3. Lung Cancer Diagnostic Tests Market Restraints in Global Market
Table 4. Key Players of Lung Cancer Diagnostic Tests in Global Market
Table 5. Top Lung Cancer Diagnostic Tests Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Lung Cancer Diagnostic Tests Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Lung Cancer Diagnostic Tests Revenue Share by Companies, 2018-2023
Table 8. Global Companies Lung Cancer Diagnostic Tests Product Type
Table 9. List of Global Tier 1 Lung Cancer Diagnostic Tests Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lung Cancer Diagnostic Tests Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Lung Cancer Diagnostic Tests Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Lung Cancer Diagnostic Tests Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Lung Cancer Diagnostic Tests Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Lung Cancer Diagnostic Tests Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Lung Cancer Diagnostic Tests Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Lung Cancer Diagnostic Tests Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2024-2030
Table 30. Advpharma Inc Company Summary
Table 31. Advpharma Inc Lung Cancer Diagnostic Tests Product Offerings
Table 32. Advpharma Inc Lung Cancer Diagnostic Tests Revenue (US$, Mn) & (2018-2023)
Table 33. Advpharma Inc Key News & Latest Developments
Table 34. AIT Austrian Institute of Technology GmbH Company Summary
Table 35. AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Product Offerings
Table 36. AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Revenue (US$, Mn) & (2018-2023)
Table 37. AIT Austrian Institute of Technology GmbH Key News & Latest Developments
Table 38. Courtagen Life Sciences Inc Company Summary
Table 39. Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Product Offerings
Table 40. Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Revenue (US$, Mn) & (2018-2023)
Table 41. Courtagen Life Sciences Inc Key News & Latest Developments
Table 42. DiagnoCure Inc. (Inactive) Company Summary
Table 43. DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Product Offerings
Table 44. DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Revenue (US$, Mn) & (2018-2023)
Table 45. DiagnoCure Inc. (Inactive) Key News & Latest Developments
Table 46. BioMark Diagnostics Inc. Company Summary
Table 47. BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Product Offerings
Table 48. BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Revenue (US$, Mn) & (2018-2023)
Table 49. BioMark Diagnostics Inc. Key News & Latest Developments
Table 50. BioMarker Strategies LLC Company Summary
Table 51. BioMarker Strategies LLC Lung Cancer Diagnostic Tests Product Offerings
Table 52. BioMarker Strategies LLC Lung Cancer Diagnostic Tests Revenue (US$, Mn) & (2018-2023)
Table 53. BioMarker Strategies LLC Key News & Latest Developments
Table 54. Emory University Company Summary
Table 55. Emory University Lung Cancer Diagnostic Tests Product Offerings
Table 56. Emory University Lung Cancer Diagnostic Tests Revenue (US$, Mn) & (2018-2023)
Table 57. Emory University Key News & Latest Developments
Table 58. Epigenomics AG Company Summary
Table 59. Epigenomics AG Lung Cancer Diagnostic Tests Product Offerings
Table 60. Epigenomics AG Lung Cancer Diagnostic Tests Revenue (US$, Mn) & (2018-2023)
Table 61. Epigenomics AG Key News & Latest Developments
Table 62. GlycoZym Company Summary
Table 63. GlycoZym Lung Cancer Diagnostic Tests Product Offerings
Table 64. GlycoZym Lung Cancer Diagnostic Tests Revenue (US$, Mn) & (2018-2023)
Table 65. GlycoZym Key News & Latest Developments
Table 66. HalioDx SAS Company Summary
Table 67. HalioDx SAS Lung Cancer Diagnostic Tests Product Offerings
Table 68. HalioDx SAS Lung Cancer Diagnostic Tests Revenue (US$, Mn) & (2018-2023)
Table 69. HalioDx SAS Key News & Latest Developments
Table 70. Louisville Bioscience, Inc. Company Summary
Table 71. Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Product Offerings
Table 72. Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Revenue (US$, Mn) & (2018-2023)
Table 73. Louisville Bioscience, Inc. Key News & Latest Developments
Table 74. Mayo Clinic US Company Summary
Table 75. Mayo Clinic US Lung Cancer Diagnostic Tests Product Offerings
Table 76. Mayo Clinic US Lung Cancer Diagnostic Tests Revenue (US$, Mn) & (2018-2023)
Table 77. Mayo Clinic US Key News & Latest Developments
List of Figures
Figure 1. Lung Cancer Diagnostic Tests Segment by Type in 2022
Figure 2. Lung Cancer Diagnostic Tests Segment by Application in 2022
Figure 3. Global Lung Cancer Diagnostic Tests Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Lung Cancer Diagnostic Tests Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Lung Cancer Diagnostic Tests Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Lung Cancer Diagnostic Tests Revenue in 2022
Figure 8. By Type - Global Lung Cancer Diagnostic Tests Revenue Market Share, 2018-2030
Figure 9. By Application - Global Lung Cancer Diagnostic Tests Revenue Market Share, 2018-2030
Figure 10. By Type - Global Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Lung Cancer Diagnostic Tests Revenue Market Share, 2018-2030
Figure 12. By Application - Global Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Lung Cancer Diagnostic Tests Revenue Market Share, 2018-2030
Figure 14. By Region - Global Lung Cancer Diagnostic Tests Revenue Market Share, 2018-2030
Figure 15. By Country - North America Lung Cancer Diagnostic Tests Revenue Market Share, 2018-2030
Figure 16. US Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Lung Cancer Diagnostic Tests Revenue Market Share, 2018-2030
Figure 20. Germany Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2018-2030
Figure 21. France Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Lung Cancer Diagnostic Tests Revenue Market Share, 2018-2030
Figure 28. China Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2018-2030
Figure 32. India Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Lung Cancer Diagnostic Tests Revenue Market Share, 2018-2030
Figure 34. Brazil Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Lung Cancer Diagnostic Tests Revenue Market Share, 2018-2030
Figure 37. Turkey Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2018-2030
Figure 41. Advpharma Inc Lung Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. BioMarker Strategies LLC Lung Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Emory University Lung Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Epigenomics AG Lung Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. GlycoZym Lung Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. HalioDx SAS Lung Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Mayo Clinic US Lung Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
